Sign in

CIK 0001813814

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Definium Therapeutics, Inc.

Sign in to watch
Ticker
DFTX
Exchange
Nasdaq
Industry
Medicinal Chemicals & Botanical Products
FY end
Dec 31
Incorporated
British Columbia, Canada
Entity type
Operating
Phone
+1 212-220-6633
Business address
ONE WORLD TRADE CENTER, SUITE 8500, NEW YORK, NY, 10007
Former names
Mind Medicine (MindMed) Inc.
  1. 3 Insider Initial Statement of Ownership
  2. 4/A Open-market sale Chief Executive Officer sold 18,948 shares at $0.71 ($13,453)
  3. 4 Shares withheld for taxes Chief Executive Officer gave up 18,948 shares (to pay taxes)
  4. 4 Shares withheld for taxes Chief Medical Officer gave up 13,038 shares (to pay taxes)
  5. 4 Shares withheld for taxes Chief Executive Officer gave up 19,110 shares (to pay taxes)
  6. 4 Shares withheld for taxes Chief Medical Officer gave up 10,203 shares (to pay taxes)
  7. 4 Grant or award Chief Legal Officer&Secretary acquired 1,200,000 shares (grant or award)
  8. 4 Grant or award Executive President acquired 600,000 shares (grant or award)
  9. 4 Grant or award Chief Medical Officer acquired 950,000 shares (grant or award)
  10. 4 Grant or award Chief Executive Officer acquired 1,820,000 shares (grant or award)
  11. 4 Insider Changes in Ownership
  12. 4 Shares withheld for taxes Chief Executive Officer gave up 12,612 shares (to pay taxes)
  13. 4 Grant or award VP, Controller&Acct Principal acquired 403,430 shares (grant or award)
  14. 4 Shares withheld for taxes Chief Medical Officer gave up 118,143 shares (to pay taxes)
  15. 4 Shares withheld for taxes Chief Executive Officer gave up 18,734 shares (to pay taxes)
  16. 4 Shares withheld for taxes Chief Executive Officer gave up 190,287 shares (to pay taxes)
  17. 3 Insider Initial Statement of Ownership
  18. 3 Insider Initial Statement of Ownership
  19. 3 Insider Initial Statement of Ownership
  20. 3 Insider Initial Statement of Ownership

Page 9 of 10 · 186 filings